Development of Novel Immunomodulatory Nanoparticle for Treating Lymphangioleiomyomatosis

Proposes a CpG-ODN-loaded PEI-PEG nanoparticle delivered intranasally to target lung-draining lymph…

• Unmet Clinical Need
• Novel Delivery Platform
• Underpowered Cohorts
• Inflammation Endpoints Thin